CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on advancing personalized cancer vaccines that target individual mutations in tumors. By addressing challenges in vaccine design and immune response, it aims to enhance the effectiveness of mRNA-based therapies for diverse cancer types.
Immunotherapy is expected to fundamentally change the treatment of cancer patients.
Personalized vaccines elicitingimmune responses against individual cancer mutations have moved into the spotlight.
We have pioneered the field andmoved ´cancer mutanome vaccines´ from a mere vision into a disruptive medical concept compatible with currentstandards of drug development and health care practice.
Solving key scientific and technological challenges and buildingon extensive preclinical studies, we show…
TRON - TRANSLATIONALE ONKOLOGIE ANDER UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ GEMEINNUTZIGE GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
